That 1b valuation is a nice comp. especially since vicarious is still early stage and unproven. 4 patents and it would appear they are tripping over both ISRG and TMDI.
One thing appears true. Single incision will be the next frontier.
Overall good maybe great news for titan valuation wise.
News 
Market Data 
Discover 
